Inventor · disambiguated record
Lai-Ming Ching
Also filed as: CHING LAI-MING
7 granted patents·5 pending applications·337 citations·filing 2001–2023
85Inventor score
Top patents by PatentIndex Score
12 records- 0194US7585893B2Anti-cancer composition comprising DMXAA or related compoundCANCER REC TECH LTD·Filed 2005·Granted Sep 8, 2009·109 cites·9 claims
- 0292US7510830B2Cancer treatment by combination therapyCANCER REC TECH LTD·Filed 2003·Granted Mar 31, 2009·115 cites·12 claims
- 0392US7462642B2Anti-cancer combinationsCANCER REC TECH LTD·Filed 2004·Granted Dec 9, 2008·110 cites·6 claims
- 0486US10888567B2Inhibitors of tryptophan dioxygenases (IDO1 and TDO) and their use in therapyAUCKLAND UNISERVICES LTD·Filed 2015·Granted Jan 12, 2021·2 cites·4 claims
- 0585US11826316B2Inhibitors of tryptophan dioxygenases (IDO1 and TDO) and their use in therapyAUCKLAND UNISERVICES LTD·Filed 2020·Granted Nov 28, 2023·1 cites·12 claims
- 0679US12508268B2Inhibitors of tryptophan dioxygenases (IDO1 and TDO) and their use in therapyAUCKLAND UNISERVICES LTD·Filed 2023·Granted Dec 30, 2025·0 cites·25 claims
- 0766US2022411438A1Inhibitors of Tryptophan Dioxygenases (IDO1 and TDO) And Their Use In TherapyAUCKLAND UNISERVICES LTD·Filed 2022·Application pending·0 cites
- 0855US2009062377A1Anti-cancer combinationsCANCER REC TECH LTD·Filed 2008·Application pending·0 cites
- 0953US2008167272A1Thalidomide metabolites and methods of useAUCKLAND UNISERVICES LTD·Filed 2006·Application pending·0 cites
- 1052US11414428B2Inhibitors of tryptophan dioxygenases (IDO1 and TDO) and their use in therapyAUCKLAND UNISERVICES LTD·Filed 2016·Granted Aug 16, 2022·0 cites·21 claims
- 1143US2007082937A1Anti cancer combinations comprising a cox-2 inhibitorCANCER REC TECH LTD·Filed 2004·Application pending·0 cites
- 1236US2004086498A9Cancer therapyFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lai-Ming Ching files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →